Gayer Charles K bought BCRX
December 22, 2025 · Form 4 insider transaction
Gayer Charles K bought 14,142 shares of BioCryst Pharmaceuticals, Inc. at $3.22 per share, a transaction worth $45.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
14,142
Price
$3.22
Total value
$45.5K
InsiderGayer Charles K
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 22, 2025
Filing dateDecember 23, 2025
Shares owned after892,492
OwnershipDirect
10b5-1 planNo
AmendedNo